Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

Peripheral T-cell lymphoma (PTCL) is a group of diseases with poor outcome and few therapeutic options. We aimed to assess the efficacy of bendamustine in real life cohort of patients. Between November 2009 and March 2015, 138 PTCL patients were treated with bendamustine in 27 centers. Population me...

Descripción completa

Detalles Bibliográficos
Autores principales: Reboursiere, Emilie, Bras, Fabien Le, Herbaux, Charles, Gyan, Emmanuel, Clavert, Aline, Morschhauser, Franck, Malak, Sandra, Sibon, David, Broussais, Florence, Braun, Thorsten, Fornecker, Luc-Matthieu, Garidi, Reda, Tricot, Sabine, Houot, Roch, Joly, Bertrand, Abarah, Wajed, Choufi, Bachra, Pham, Anne-Dominique, Gac, Anne-Claire, Fruchart, Christophe, Marin, Emilie, Safar, Violaine, Parcelier, Anne, Maisonneuve, Hervé, Bachy, Emmanuel, Cartron, Guillaume, Jaccard, Arnaud, Tournilhac, Olivier, Rossi, Cédric, Schirmer, Luciane, Martignoles, Jean-Alain, Gaulard, Philippe, Tilly, Hervé, Damaj, Gandhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356759/
https://www.ncbi.nlm.nih.gov/pubmed/27458168
http://dx.doi.org/10.18632/oncotarget.10764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356759/
https://www.ncbi.nlm.nih.gov/pubmed/27458168
http://dx.doi.org/10.18632/oncotarget.10764

Ejemplares similares